Barclays’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,019
| Closed | -$13K | – | 4279 |
|
|
2021
Q1 | $13K | Buy |
+9,019
| New | +$13K | ﹤0.01% | 3699 |
|
|
2019
Q4 | – | Sell |
-8,224
| Closed | -$32K | – | 4383 |
|
|
2019
Q3 | $32K | Sell |
8,224
-2,016
| -20% | -$7.84K | ﹤0.01% | 3785 |
|
|
2019
Q2 | $41K | Buy |
10,240
+6,963
| +212% | +$27.9K | ﹤0.01% | 3873 |
|
|
2019
Q1 | $23K | Buy |
+3,277
| New | +$23K | ﹤0.01% | 3884 |
|
|
2018
Q4 | – | Sell |
-4,629
| Closed | -$49K | – | 4525 |
|
|
2018
Q3 | $49K | Buy |
4,629
+3,779
| +445% | +$40K | ﹤0.01% | 3745 |
|
|
2018
Q2 | $11K | Sell |
850
-272
| -24% | -$3.52K | ﹤0.01% | 3880 |
|
|
2018
Q1 | $13K | Buy |
1,122
+268
| +31% | +$3.11K | ﹤0.01% | 3914 |
|
|
2017
Q4 | $9K | Buy |
+854
| New | +$9K | ﹤0.01% | 3835 |
|